Movement Disorders Drugs

Random Miscellaneous Quiz

Can you name the Movement Disorders Drugs?

Quiz not verified by Sporcle

 plays        
How to Play
HintAnswer
Use: prolong ALS survival by months
P-kinetics: Readily absorbed from intestines (depends on rate of gastric emptying and pH -- delayed by food). Some other AAs can compete for transport across the BBB.
Orphenadrine class
SE: GI: anorexia, n/v, constipation, dyspepsia, peptic ulcers, symptoms of reflux esophagitis. CV: postural hypotension & cardiac arrhythmias. Dyskinesias.
Contraindications: psychotic pts, angle closure glaucoma (Increased IOP), active peptic ulcers, hx of melanoma (melanin precursor)
P-kinetics: Given PO. Loses effectiveness over time.
Use: Can be used as 1st line tx for Parkinson's dz - often in combo w/ Sinemet. Commonly used to tx hyperprolactinemia.
MOA: Central (brain) anti-cholinergic
Olanzapine class
SE: Ergoline-induced toxicity effects unlikely. Postural hypotension, fatigue, somnolence, peripheral edema, nausea, constipation, dyskinesias, & confusion.
MOA: Increases dopamine release & reduces dopamine reuptake into dopaminergic nerve terminals of substantia nigra neurons. Unknown MOA.
Contraindications: psychotic illness, MI hx, PVD, peptic ulcers
P-kinetics: SQ. Rapid onset ~ 10 min. Duration 2 hrs
SE: Mental Disturbances: confusion, hallucinations, delusions, other psychiatric reactions.
Quetiapine class
SE: Nausea (pretreat w/ anti-emetic - trimethobenzamide or domiperidone), dyskinesias, drowsiness, sweating, hypotension
MOA: Pure D2 receptor agonist
SE: Dyskinesias: chorea, ballismus, athetosis, dystonia, myoclonus, tics, tremors. Behavioral effects: anxiety/ agitation, insomnia/ somnolence, confusion/ delusions/ hallucination
SE: Increased L-dopa toxicity (dyskinesias, nausea, & confusion), diarrhea, abd pain, orthostatic hypotension, sleep disturbances, & orange urine.
Haloperidol class
Trihexyphenidyl class
Use: Reduced response to fluctuations w/ L-dopa. Decreased L-dopa clearance. Decreased dopa decarboxylase --> compensatory increase in COMT.
Reserpine class
P-kinetics: Start at low dose & gradually increase
Carbidopa + levidopa (1:10 or 1:4)
SE: May interfere with uptake - Rx metabolizes L-dopa into 3-methyldopa which competes for active transport across the BBB.
TCA class
Pramipexole class
Pergolide class
Use: May improve tremor & rigidity in Parkinsons. Little effect on bradykinesia.
Tolcapone class
MOA: Preferential affinity for D3 family of receptors
HintAnswer
Group P-kinetics: Advantages: No enzymatic conversion required, crosses BBB w/o competing for amino acid transporter. No potentially toxic metabolites
Use: Huntington's dz pts w/ psychosis or disruptive behavior. Also helpful w/ chorea
Riluzole class
Use: alleviation of chorea if refractory to atypical
P-kinetics: 2/3 appears in urine as metabolites within 8 hrs (homovanillic acid - HVA and dihydrocyphenylacetic acid - DOPAC). Best response is in the first few yrs of tx.
Entacapone class
Use: Most effective drug in tx of Tourette's
Use: Similar to Bromocriptine, but more effective. May benefit pts not receiving L-dopa. Aids pt w/ response fluctuations to L-dopa
Use: alleviation of chorea
Procyclidine class
MOA: Prevents the metabolism of L-dopa --> 3-O-methyldopa (3OMD) by Catechol-0-methyltransferase
MOA: Inhibits the L-dopa --> dopamine conversion by dopa decarboxylase in the periphery (does not cross BBB).
Use: Temporary relief of off-period akinesia in Parkinsons. Also used to tx ED.
SE: Other: dry mouth, blurred vision, mydriasis, urinary retention, n/v, constipation, tachycardia, increased IOP.
MOA: D1 and D2 receptor agonist
Use: Similar to Pramipexole
Biperiden class
P-kinetics: Start with a small dose
Fluphenzaine class
Interactions: Vitamin B6 enhances the extracerebral metabolism of L-dopa. MAOI w/ L-dopa can --> HTNive crisis if given within 2 weeks of each other.
SE: Insomnia when taken late in the day
Levodopa class
Tetrabenxine class
Interactions: Should not be taken w/ meperidine, TCAs, serotonin reuptake inhibitors, or in combo w/ nonspecific MAOIs
Clonidine class
Apomorphine class
Ropinirole class
Use: Gold standard in Parkinson's dz - most efficacious treatment
Use: depression associated with Huntington's disease
MOA: Dopamine precursor able to cross the BBB where it is decarboxylated by dopa decarboxylase to form dopamine.
Benzotropine class
SE: If adverse effects become too severe withdraw gradually. break for 3-21 days, and reinstate gradually
HintAnswer
Clonazepam class
MOA: Somewhat selective MAO-B inhibitors. Retard the breakdown of dopamine
P-kinetics: Variable absorption from GI, peak plasma levels 1-2 hrs post PO dose. Excreted in bile & feces. Build up dose slowly over 2-3 mo to avoid adverse effects
Use: Increases amount of L-dopa able to cross the BBB. Combo with L-dopa allows for L-dopa dose reduction up to 85%.
SE: CNS: drowsiness, mental slowness, inattention, restless, confusion, agitation, delusions, hallucinations, & mood changes.
MOA: Not completely known. Inhib effects on glutamate-R, NMDA antag, Inactivation of voltage gated Na+ channels. Interferes w/ intracellular events post excitatory AA-R activation
SE: HA, nasal congestion, increased arousal, pulmonary infiltrates, ergoline-induced s/s, erythromelagia, vasospasm, & pleural or retroperitoneal fibroses.
P-kinetics: Well absorbed orally. T1/2 ~ 12 hrs. Hepatic metabolism (cytochrome P450, CYP1A2) -- caution in pts w/ hepatic insufficiency.
SE: Asthenia, dizziness, GI disorders, & elevation of liver enzymes.
P-kinetics: Only 1-3% enters the brain across BBB unaltered. Peak plasma levels 1-2 hrs post PO dose. Plasma t1/2 = 1-2 hrs (pts vary -- dosing 3-4x/day).
MOA: D2 receptor agonist (partial D1 agonist)
Bromocriptine class
P-kinetics: Similar to Pramipexole
Butyrophenones class
Phenothiazine class
SE: CV: Increased HR, PVCs, A fib (rare), postural hypotension, HTN (usually in the presence of non-specific MAOI or with large doses).
Use: Monotherapy for mild Parkinsonism or combo tx for advanced pts. Reduces L-dopa dose & smooths response fluctuations. Putative neuroprotective effects (scavenges free radicals)
Use: Enhance & prolong the effects of L-dopa; reduce response fluctuations; lowers necessary dose of L-dopa. ?Antioxidant properties?
SE: GI (L-dopa alone): anorexia, n/v (avoid anti-emetics like phenothiazines d/t their extrapyramidal effects -- dopamine antagonist; carbidopa reduces these effects.
Carbidopa class
P-kinetics: Only helpful for Huntington's dz chorea at very high doses
Selegiline class
P-kinetics: Rapid PO absorption, excreted unchanged in urine, gradually increase dose
SSRI class
P-kinetics: Response can decline over time or stop completely. Start at small dose & escalate as effects diminish. Wearing off rxs. Toxicity concern is supersensitivity develpmnt -
P-kinetics: Note: Antidepressant MAOIs are either nonspecific or inhibit MAO-A more specifically (5-HT & NE)
Amantadine class
SE: May be hepatotoxic - (needs signed pt consent & liver monitoring Q 2 wks x 1 yr)
Rasagiline class
Contraindications: Prostatic hyperplasia, obstructive GI dz, & angle-closure glaucoma
Risperidone class
Carbamazepine class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 8, 2011ReportNominate
Tags:disorder, drug, movement